Antiallergisia

Antiallergisia is a term used to describe a broad set of strategies and interventions aimed at reducing the risk, frequency, and severity of allergic reactions. It is not a formal disease name in most medical vocabularies, but it is used to discuss approaches to prevent and manage allergic diseases such as allergic rhinitis, asthma, atopic dermatitis, and some food allergies.

Core goals include minimizing exposure to known allergens and modulating the immune response to those allergens. Practical components include allergen avoidance strategies, symptom-relieving medications (for example, antihistamines, nasal corticosteroids, and leukotriene receptor antagonists), and strategies designed to change the body's response to allergens, such as immunotherapy (subcutaneous or sublingual). Immunotherapy gradually increases tolerance to specific allergens and can reduce long-term disease activity.

Advanced therapies involve biologic agents that target immune pathways implicated in allergic disease, such as anti-IgE or anti-IL-4/IL-13 therapies, used in selected patients. In food allergies, controlled oral immunotherapy may be offered in specialized centers. Safety considerations, individual risk assessment, and professional supervision are essential, as treatments vary in efficacy and potential side effects. The term reflects an integrated, patient-centered approach to allergy care rather than a single treatment.